<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00473993</url>
  </required_header>
  <id_info>
    <org_study_id>HepCOP Zurich</org_study_id>
    <nct_id>NCT00473993</nct_id>
  </id_info>
  <brief_title>Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland</brief_title>
  <acronym>HepCOP</acronym>
  <official_title>Hepatitis C Bei Opioidabhängigen in Der Praxis, Eine Querschnittsuntersuchung</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seidenberg, Arztpraxis A., M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seidenberg, Arztpraxis A., M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatitis C viral infection is common among opioid addicts in Zurich, Switzerland. The
      majority undergoes a maintenance treatment with methadone, heroin or buprenorphine. While
      stabilized by an opioid maintenance treatment (OMT)chronic hepatitis C can be treated with
      pegylated interferon plus ribavirin. As not sufficiently known, the results are comparable to
      the results of the treatment of nonaddicts.

      Our crossectional study investigates how many patients undergoing OMT are adequately
      investigated concerning hepatitis C. If not, why are they not adequately investigated and
      treated? Representative data are collected in the local clinics and medical practices
      involved in OMT in the Kanton of Zurich. The patients files are revised and the involved
      doctors are asked through a structured interview.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      www.seidenberg.ch/hepcop.pdf
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <condition>Hepatitis C, Chronic</condition>
  <condition>Substance Abuse Treatment Centers</condition>
  <condition>Opioid-Related Disorders</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in opioid maintenance treatment in the kanton of Zurich, Switzerland
      </textblock>
    </study_pop>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Medical practices and clinics involved in opioid maintenance treatment in the Kanton
             of Zurich, Switzerland
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>André Seidenberg, Dr.med.</last_name>
    <role>Study Director</role>
    <affiliation>research fellow EHAM, University of Zurich</affiliation>
  </overall_official>
  <link>
    <url>http://www.seidenberg.ch/media/hepcop.pdf</url>
    <description>download of the protocol of the HepCOP-study</description>
  </link>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2007</study_first_submitted>
  <study_first_submitted_qc>May 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2007</study_first_posted>
  <last_update_submitted>February 13, 2009</last_update_submitted>
  <last_update_submitted_qc>February 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2009</last_update_posted>
  <keyword>Hepatitis C</keyword>
  <keyword>Opioid Maintenance Treatment</keyword>
  <keyword>Methadone</keyword>
  <keyword>Buprenorphine</keyword>
  <keyword>Heroin</keyword>
  <keyword>Interferon, pegylated</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
    <mesh_term>Opioid-Related Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

